InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+4.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Kearney Terrence C, Director. Director active across 2 companies, notably Acceleron Pharma INC. In total, 3 disclosures have been published. Activity tracked since 1 May 2022. The latest transaction was filed on 10 August 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
10,000 shares@ US$127.54100.0% of flowCommon StockSEC:0000899243-23-018113:0
725 shares0Common StockSEC:0000899243-22-016384:0
6,749 sharesCommon StockSEC:0001104659-21-142274:0
3 of 3 declarations
About Kearney Terrence C
Terrence C. Kearney is a Director at ACCELERON PHARMA INC and VERTEX PHARMACEUTICALS INC / MA. He contributes to the governance of these companies by bringing his expertise in strategy and business development. Terrence is involved in key decisions that influence the future of these firms.
